Cargando…
Improvement of Type 2 Diabetes Mellitus and Attenuation of NAFLD Are Associated with the Success of Obesity Therapy
Obesity and type 2 diabetes mellitus (T2D) represent important comorbidities of the metabolic syndrome, which are associated with non-alcoholic fatty liver disease (NAFLD)-related hepatic fibrosis. In total, 160 morbidly obese patients—81 following a low-calorie formula diet (LCD) program and 79 und...
Autores principales: | Schmid, Andreas, Arians, Miriam, Karrasch, Thomas, Pons-Kühnemann, Jörn, Schäffler, Andreas, Roderfeld, Martin, Roeb, Elke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999703/ https://www.ncbi.nlm.nih.gov/pubmed/35407364 http://dx.doi.org/10.3390/jcm11071756 |
Ejemplares similares
-
Circulating Adipokines and Hepatokines Serve as Diagnostic Markers during Obesity Therapy
por: Schmid, Andreas, et al.
Publicado: (2022) -
Caspase-Cleaved Keratin 18 Measurements Identified Ongoing Liver Injury after Bariatric Surgery
por: Hempel, Felix, et al.
Publicado: (2021) -
C1q/TNF-Related Protein 3 (CTRP-3) Deficiency of Adipocytes Affects White Adipose Tissue Mass but Not Systemic CTRP-3 Concentrations
por: Schmid, Andreas, et al.
Publicado: (2021) -
Depletion of Bone Marrow-Derived Fibrocytes Attenuates TAA-Induced Liver Fibrosis in Mice
por: Hempel, Felix, et al.
Publicado: (2019) -
Meteorin-Like Protein (Metrnl) in Obesity, during Weight Loss and in Adipocyte Differentiation
por: Schmid, Andreas, et al.
Publicado: (2021)